PANCREATIC DUCTAL ADENOCARCINOMA

This study tested a new drug, PF-08046052/SGN-EGFRd2, in people with advanced solid tumors like colorectal, lung, head and neck, and pancreatic cancers. The goal was to find a safe dose and check for side effects. The trial was terminated early, so results are limited. It involve…

This study tested a combination of two drugs (niraparib and dostarlimab) in adults with advanced solid tumors that either had DNA repair defects or were sensitive to platinum chemotherapy. The goal was to see how many patients' tumors shrank or disappeared. The trial was stopped …

This early-stage study tested a new radioactive drug called 177Lu-FF58 in 24 adults with advanced pancreatic, stomach, or brain cancers that had spread or come back. The main goal was to check the drug's safety and find the right dose. The study was stopped early, so results are …

This study tested a drug called Promitil in 19 people with ovarian or pancreatic cancer that had specific gene mutations (BRCA or HRD) and had stopped responding to first treatment. The goal was to see if the drug could slow cancer growth and be safe. The trial was ended early, s…

This study tested whether surgically removing small tumors in the liver or lungs could help people with pancreatic cancer live longer. Only 5 people took part before the study was stopped early. Participants first received chemotherapy, then had surgery to remove the cancer that …

This early-stage trial tested a new drug called BI 765883, given alone or with chemotherapy, for people with advanced pancreatic cancer that had spread or returned after surgery. The study aimed to find a safe dose and see if the drug could shrink tumors. Only 8 people took part …

This study tested a new drug called DCC-3084, alone or with other cancer treatments, in people with advanced solid tumors that have certain gene changes (MAPK pathway). The trial aimed to find safe doses and see if the drug could shrink tumors. It was stopped early after enrollin…

This study tested a new radioactive dye called [68Ga]-FF58 to see how well it lights up certain cancers on PET scans. The dye targets specific proteins found on some brain, stomach, and pancreatic tumors. The study was stopped early, but the goal was to learn about the dye's safe…

This study aimed to see if the antidepressant escitalopram could reduce depression in people with localized pancreatic cancer who were receiving chemotherapy. Only 4 participants were enrolled before the study was stopped early. The approach was to compare escitalopram to a place…